Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · IEX Real-Time Price · USD
1.420
+0.030 (2.16%)
Jul 22, 2024, 9:30 AM EDT - Market open
Dyadic International Employees
Dyadic International had 7 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
7
Change
n/a
Growth
n/a
Revenue / Employee
$322,196
Profits / Employee
-$1,121,230
Market Cap
40.64M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Nortech Systems | 775 |
Co-Diagnostics | 155 |
Owlet | 76 |
OncoCyte | 46 |
Movano | 30 |
Tempest Therapeutics | 17 |
Incannex Healthcare | 10 |
ProMIS Neurosciences | 7 |
DYAI News
- 24 days ago - Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership - GlobeNewsWire
- 7 weeks ago - Dyadic to Attend Industry Events in June - GlobeNewsWire
- 2 months ago - Dyadic Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress - GlobeNewsWire
- 2 months ago - Dyadic to Attend Industry and Investor Events in May - GlobeNewsWire
- 2 months ago - Dyadic to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024 - GlobeNewsWire
- 4 months ago - Dyadic Reports 2023 Full Year Results and Recent Company Progress - GlobeNewsWire
- 4 months ago - Dyadic Announces Change in Board and Management Leadership Roles - GlobeNewsWire
- 4 months ago - Dyadic to Attend Industry Events in April - GlobeNewsWire